Peptidic Tumor Targeting Agents: The Road from Phage Display Peptide Selections to Clinical Applications

E-ISSN： 1873-4286|16|9|1040-1054

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.16, Iss.9, 2010-03, pp. : 1040-1054

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Identification of Tumor Targeting Agents by Phage Display

Medicinal Chemistry Reviews - Online, Vol. 2, Iss. 3, 2005-06 ,pp. : 219-229

Bentham Science Publishers

Access to resources Recommend Favorite

Novel β-lactamase-random peptide fusion libraries for phage display selection of cancer cell-targeting agents suitable for enzyme prodrug therapy

By Shukla Girja S. Krag David N.

Journal of Drug Targeting, Vol. 18, Iss. 2, 2010-02 ,pp. : 115-124

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Atypical Chemokine Receptor ACKR3/CXCR7: Phase 1 - Phage Display Peptide Identification and Characterization

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 13, 2016-05 ,pp. : 1427-1440

Bentham Science Publishers

Access to resources Recommend Favorite

Phage Display Applications for Molecular Imaging

Current Pharmaceutical Biotechnology, Vol. 11, Iss. 6, 2010-01 ,pp. : 603-609

Bentham Science Publishers

Access to resources Recommend Favorite

Identification of a novel peptide ligand targeting visceral adipose tissue via transdermal route by in vivo phage display

By Lee Nam Kyung Kim Hong Shin Kim Kyung Hyun Kim Eun-Bae Cho Chong Su Kang Sang Kee Choi Yun Jaie

Journal of Drug Targeting, Vol. 19, Iss. 9, 2011-11 ,pp. : 805-813

Informa Healthcare

Access to resources Recommend Favorite